NSE ScannerComparison · NSE · data 2026-10-31
Aarey Drugs & Pharmaceuticals Ltd. vs Albert David Ltd
In plain words
Size: Albert David Ltd is about 1.5 times the market value of Aarey Drugs & Pharmaceuticals Ltd..
Valuation (P/E): Aarey Drugs & Pharmaceuticals Ltd. 72.4 vs Albert David Ltd 19.3.
Return on equity: Aarey Drugs & Pharmaceuticals Ltd. 2.7% vs Albert David Ltd -0.4%.
Debt to equity: Aarey Drugs & Pharmaceuticals Ltd. 0.33 vs Albert David Ltd 0.08.
Differences in the numbers, not a recommendation of either stock.
Side by side
| AAREYDRUGS | ALBERTDAVD | |
|---|---|---|
| Price | ₹106.26 | ₹762.8 |
| Market cap | ₹298 cr | ₹435 cr |
| P/E | 72.4 | 19.3 |
| P/B | — | — |
| ROE | 2.7% | -0.4% |
| ROCE | 6.0% | 0.3% |
| Debt / equity | 0.33 | 0.08 |
| Operating margin | 0.9% | 4.7% |
| Dividend yield | 0.00% | 0.66% |
| Sales growth, 3 years (yearly) | 4.1% | -0.8% |
| Profit growth, 3 years (yearly) | 1.7% | — |
| 1-year return | 15.4% | -11.0% |
| Revenue, last 12 months | ₹415 cr | ₹364 cr |
| Net profit, last 12 months | ₹4 cr | ₹23 cr |
| Latest quarter | Jun 2026 | Jun 2026 |
| Quarter net profit | ₹1 cr | ₹32 cr |
| Quarter profit vs a year earlier | -25.5% | +303.0% |
| Promoter holding | 41.45% | 62.24% |
| Health check | Weak (3.6/10) | Average (5.9/10) |
Common questions
Which has a higher P/E, Aarey Drugs & Pharmaceuticals Ltd. or Albert David Ltd?
Aarey Drugs & Pharmaceuticals Ltd. trades at the higher P/E (72.4 against 19.3). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Aarey Drugs & Pharmaceuticals Ltd. (2.7% against -0.4%).
Which carries more debt?
Aarey Drugs & Pharmaceuticals Ltd. has the higher debt-to-equity ratio (0.33 against 0.08).